AI assistant
Sending…
PLUS THERAPEUTICS, INC. — Director's Dealing 2024
Sep 13, 2024
34301_dirs_2024-09-13_25a7a90d-63bd-4afc-aaae-2fe0eaa69b68.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PLUS THERAPEUTICS, INC. (PSTV)
CIK: 0001095981
Period of Report: 2024-09-11
Reporting Person: Petersen Greg (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-09-11 | Common Stock | P | 12500 | $1.35 | Acquired | 48921 | Direct |
More from PLUS THERAPEUTICS, INC.
Regulatory Filings
2026
Jun 5
Capital/Financing Update
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 15
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Regulatory Filings
2026
Apr 21
Board/Management Information
2026
Apr 9
Regulatory Filings
2026
Apr 8
Board/Management Information
2026
Mar 26
Director's Dealing
2026
Feb 27